89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer - Concepedia

Concepedia

Publication | Open Access

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

DOI Full Paper Access

84

Citations

18

References

2021

Year

Iris C. Kok, J.S. Hooiveld, Pim P. van de Donk, Danique Giesen, Elly L. van der Veen, Marjolijn N. Lub–de Hooge, Adrienne H. Brouwers, T. Jeroen N. Hiltermann, Anthonie J. van der Wekken, Lucie B.M. Hijmering-Kappelle,

Annals of Oncology

Abstract

<sup>89</sup>Zr-pembrolizumab uptake in tumor lesions correlated with treatment response and patient survival. <sup>89</sup>Zr-pembrolizumab also showed uptake in lymphoid tissues and at sites of inflammation.

References

	Year	Citations

Page 1